510(k) device
Chemo Mouthpiece
Chemo Mouthpiece, LLC · Intraoral Cooling Device (QUA, Class II) · First FDA decision Jan 23, 2024, newest Jan 23, 2024
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "Chemo Mouthpiece"
MAUDE reports
0
Brand "Chemo Mouthpiece", since 2015
PubMed studies
0
Mentioning "Chemo Mouthpiece"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Chemo Mouthpiece
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Chemo MouthpieceBreakthrough510(k)
K232917 · Decided Jan 23, 2024 · 126 days after receipt
Device type: Intraoral Cooling Device (QUA) · Dentistry & Oral Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Chemo Mouthpiece", any status and sponsor, newest update first.
MuReva Phototherapy Inc.Not on our public-company list
NCT03972527 · 85 participants · Start Aug 5, 2022 · Primary completion Jun 26, 2024
Device: Photobiomodulation · For: Oral Mucositis (Ulcerative); Oral Mucositis (Ulcerative) Due to Radiation; Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy and 1 more
Sites: Birmingham, Alabama; Long Beach, California; Miami, Florida · 12 sites in all
- A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral MucositisPivotal-lookingCompleted
Chemo MouthpieceNot on our public-company list
NCT04595838 · 176 participants · Start Aug 31, 2020 · Primary completion May 18, 2023
Device: Chemo Mouthpiece · For: Oral Mucositis
Sites: Costa Mesa, California; Goshen, Indiana; Farmington Hills, Michigan · 11 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Chemo Mouthpiece", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QUA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Chemo Mouthpiece"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QUA.
- The Cooral SystemBraincool AB · De Novo 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.